Abstract
Primary cutaneous lymphomas (PCL) are a heterogeneous group of rare diseases with unique pathogenesis, prognosis and therefore treatment. Most of PCL are T-cell lymphomas (75 %) and mainly represented by Mycosis Fungoides, followed by the cutaneous CD30+ lymphoproliferative disorders. B-cell PCL belong to three main histological types, the primary cutaneous marginal zone lymphomas, the primary cutaneous follicle center lymphomas and the primary cutaneous diffuse large B-cell lymphomas, leg type. A thorough investigation is important to exclude systemic lymphoma that infiltrates the skin secondarily and to define prognosis and treatment. The main imaging staging procedure is the CT scan for the detection of lymph node enlargement and extracutaneous disease. The role of 18-FDG-PET/CT in PCL is not clear. Through small studies performed mainly in the cutaneous T-cell lymphomas, it seems to offer significant information concerning the areas of disease transformation, to guide best representative lesion for histological analysis and in the documentation of residual disease or recurrence.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pandolfino TL, Siegel RS, Kuzel TM et al (2000) Primary cutaneous B-cell lymphoma: review and current concepts. J Clin Oncol 18:2152–2168
Siegel RS, Pandolfino T, Guitart J et al (2000) Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 18:2908–2925
Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105(10):3768–3785
Schöllkopf C, Melbye M, Munksgaard L et al (2008) Borrelia infection and risk of non-Hodgkin lymphoma. Blood 111(12):5524–5529
Dijkman R, Tensen CP, Buettner M et al (2006) Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 107:4926–4929
Pasqualucci L, Bhagat G, Jankovic M et al (2008) AID is required for germinal center-derived lymphomagenesis. Nat Genet 40(1):108–112
Akhtari M, Reddy JP, Pinnix CC et al (2015) Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 12:1–5. [Epub ahead of print]
Ralfkiaer E, Cerroni L, Sander CA et al (2008) Mycosis fungoides. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
Kim YH, Liu HL, Mraz-Gernhard S et al (2003) Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 139:857–866
Vergier B, de Muret A, Beylot-Barry M et al (2000) Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. Blood 95:2212–2218
Shapiro M, Yun M, Junkins-Hopkins JM et al (2002) Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. J Am Acad Dermatol 47:623–628
Kumar R, Xiu Y, Zhuang HM, Alavi A (2006) 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma. Br J Dermatol 155:357–363
Kuo PH, McClennan BL, Carlson K et al (2008) FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol 10:74–81
Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30(1):269–291
Spaccarelli N, Gharavi M, Saboury B et al (2014) Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas. Hell J Nucl Med 17(2):78–84
Kako S, Izutsu K, Ota Y et al (2007) FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 18(10):1685–1690
Bishu S, Quigley JM, Schmitz J et al (2007) F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma 48(8):1531–1538
Tsai EY, Taur A, Espinosa L et al (2006) Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 142(5):577–584
Feeney J, Horwitz S, Gönen M, Schöder H (2010) Characterization of T-cell lymphomas by FDG PET/CT. AJR Am J Roentgenol 195(2):333–340
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Siakantaris, M.P., Nikaki, A.V., Savvidou, D.J. (2016). Primary Cutaneous Lymphomas. In: Andreou, J., Kosmidis, P., Gouliamos, A. (eds) PET/CT in Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-27380-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-27380-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27378-5
Online ISBN: 978-3-319-27380-8
eBook Packages: MedicineMedicine (R0)